Clinical Trial Update: Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating topical C-82 for psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Topical C-82 (C-82)

Snippet

Sponsor: Prism Pharma Co., Ltd. | Conditions: Psoriasis | Phase 1, Phase 2 | Status: COMPLETED